跳至主要内容
临床试验/NCT03025906
NCT03025906Unknown2 期

Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China

Xuanwu Hospital, Beijing6 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2017年2月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
120
试验地点
6
主要终点
Number of patients with effective seizure control

研究概览

简要总结

Although generalized convulsive status epilepticus (GCSE) is a life-threatening emergency, evidence-based data to guide initial drug treatment choices are lacking in the Chinese population. The investigators conduct this prospective randomized controlled trial to evaluate the relative efficacy and safety of intravenous (IV) phenobarbital (PB) and valproate (VPA) in patients with GCSE.

详细描述

After the failure of first-line diazepam treatment, patients with GCSE are randomized to receive either IV PB (standard doses, low rate) or VPA (standard). Successful treatment is considered when clinical and electroencephalographic seizure activity ceases. Adverse events following treatment and the neurological outcomes at discharge and 3 months later are also evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All consecutive GCSE patients (after the failure of first-line diazepam treatment) who were admitted in the emergency room or neurocritical care unit in Xuanwu Hospital of Capital Medical University.

排除标准

  • Unstable vital signs, such as a systolic blood pressure of <90 mm Hg, a pulse of <60 beats per min, or an arterial blood oxygen saturation of <90%,
  • Liver dysfunction (alanine transaminase or total bilirubin of more than twice the normal upper limit),
  • Neurologic emergency requiring immediate surgical intervention,
  • Pregnancy or breast feeding,
  • Hypersensitivity to study drugs.

研究组 & 干预措施

Phenobarbital

Experimental

In the PB group, a loading dose of 20 mg/kg (may give an additional 10 mg/kg) begins at a rate of 50 mg/min followed by IV 100 mg q6 h.

干预措施: Phenobarbital (Drug)

Valproate

Experimental

In the VPA group, a loading dose of 30 mg/kg (may give an additional 15 mg/kg) begins at a rate of 3 mg/kg per min followed by a continuous infusion at a rate of 1-2 mg/kg per hour.

干预措施: Valproate (Drug)

结局指标

主要结局

Number of patients with effective seizure control

时间窗: One hour after the end of the PB or VPA loading dose

The primary study endpoint is the number of patients with effective seizure control, defined as a cessation of clinical and electroencephalographic seizure activity within 1 h after administration of the phenobarbital or valproate loading dose. Effective control of GCSE is assessed clinically by one certified neurologist and also confirmed with EEG by one certified electroencephalographer.

次要结局

  • The relapse rates of SE and nonconvulsive status epilepticus (NCSE) / nonconvulsive seizures (NCS)(in the first 24 h)
  • Mortality of patients(at 30 days and at 3 months)
  • Number of patients with post-SE symptomatic epilepsy(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yingying Su

neurology department

Xuanwu Hospital, Beijing

研究点 (6)

Loading locations...

相似试验

Phenobarbital Versus Valproate for Generalized... | 临床试验